TEJSHRI GOHEL: Open Payments
NPI 1558828178 · NAPA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 15 payments from 7 companies in 2025. Trend: 2023 $266 · 2024 $318 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $64 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Biogen, Inc. | 1 | $16 |
Products named: Veozah, MYFEMBREE, Lynkuet, ACCRUFER, EVENITY, ZURZUVAE.
Industry payments across CA — which companies pay providers there.
